Jan 7, 2016 by Brian FeroldiWhy Organovo Holdings, Inc. Is Down Big TodayNo news appears to be bad news for the 3D bioprinting company.
Jan 7, 2016 by Brian FeroldiIntercept Pharmaceuticals Sold Off in December, and Here's WhyAn extended review date for its lead compound puts investors in a sour mood.
Jan 7, 2016 by Brian FeroldiWhy Shares of ACADIA Pharmaceuticals Inc. Fell off a CliffNews of a capital raise sends shares in a tailspin.
Jan 6, 2016 by Brian FeroldiWhy TherapeuticsMD Inc. Is Tanking TodayInvestors are not pleased with the company's decision to raise capital.
Jan 6, 2016 by Brian FeroldiIs MannKind Corporation's Stock Really Only Worth 5 Cents?At least one analyst seems to think so.
Jan 6, 2016 by Brian FeroldiWill CVS Health Corporation Raise Its Dividend in 2016?Will CVS Health be able to follow its recent 21% increase with another strong boost in 2016?
Jan 6, 2016 by Brian FeroldiWill 2016 Be Regeneron Pharmaceuticals Inc.'s Best Year Yet?All signs point to yes.
Jan 5, 2016 by Brian FeroldiSanofi Says Au Revoir to MannKind CorporationSanofi calls it quits and hands Afrezza back to MannKind.
Jan 4, 2016 by Brian Feroldi, Jason Hall, and Andrés CardenalThe Best ETFs for 2016Looking to buy an exchange-traded fund heading into 2016? Our contributors think you should give these three ETFs a look.
Jan 4, 2016 by Brian Feroldi3 Stocks To Buy In A Market CrashHere's my shopping list if the market were to crash.
Jan 2, 2016 by Brian FeroldiLast Week's Best Healthcare ETFIt was a bad week for the markets, but this week's top healthcare ETF still managed to eke out a small gain.
Dec 31, 2015 by Brian FeroldiWill 2016 Be CVS Health's Best Year Yet?CVS Health has many growth drivers working in its favor, which leads me to believe that 2016 will be another prosperous year.
Dec 30, 2015 by Brian FeroldiMy Biggest Money Regret of 2015Overweighting my portfolio in this one stock turned out to be a dumb decision.
Dec 30, 2015 by Brian Feroldi, Sean Williams, and Matt Frankel, CFP3 Essential Money Lessons for RetireesLearning how to become smarter with your money is crucial to long-term financial success, so here are three key money lessons we believe all retirees need to know.
Dec 30, 2015 by Brian FeroldiThe Worst 3 Biotech Stocks for 2016The year ahead is looking bleak for these 3 biotechs.
Dec 30, 2015 by Brian Feroldi, Selena Maranjian, Dan Caplinger, Brian Stoffel, Jason Hall, and Matt Frankel, CFP5 Companies We Wish We'd Bought in 2015The benefit of hindsight.
Dec 29, 2015 by Brian FeroldiThe Best ETFs for 2016Are you on the hunt for a good ETF for the year ahead? Here are three names for you to consider.
Dec 28, 2015 by Brian Feroldi, Sean Williams, and Dan CaplingerReduce Your Health Insurance Costs by Taking These 3 StepsSome suggestions for the year ahead.
Dec 26, 2015 by Brian FeroldiThe Worst Regeneron Pharmaceuticals, Inc. Headlines in 2015While 2015 was an overall success for the biotech behemoth, not all of the news was positive.
Dec 26, 2015 by Brian FeroldiLast Week's Best Healthcare ETFChristmas came early for investors in this healthcare ETF.
